Elmwood Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
CWP
FWIA
ORIO
CNB
KC
WAM
Elmwood Wealth Management's PFE Position: Q2 2026 in Review
Elmwood Wealth Management reduced its Pfizer (PFE) stake by 2.3% in Q2 2026, selling an estimated $7.93K and leaving 12,723 shares worth $306K. The position accounts for 0.08% of the portfolio, ranked #159.
Elmwood Wealth Management first reported a position in PFE in Q1 2018 and has held it in 32 quarters since. The position peaked at $1.14M in Q4 2021. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Elmwood Wealth Management held 12,723 shares of Pfizer worth $306K as of Q2 2026.
- Elmwood Wealth Management sold 303 Pfizer shares in Q2 2026, an estimated $7.93K.
- Pfizer made up 0.08% of Elmwood Wealth Management's portfolio in Q2 2026, its #159 holding.
- Elmwood Wealth Management first reported a position in Pfizer in Q1 2018 and has held it in 32 quarters since.
- Elmwood Wealth Management's Pfizer position peaked at $1.14M in Q4 2021.
- 557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Elmwood Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.